Determination of carbamazepine in fingerprints: a feasibility study to evaluate adherence in epilepsy patients
Bioanalysis · 02.05.2024 · 16 (9) · 415-427
DOI: 10.4155/bio-2023-0265 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioanalysis, online erschienen am 18.03.2024. Verfasst von Isadora Ritter Müller und 8 weiteren Autor:innen. Beteiligte Einrichtung: Analytical Toxicology Laboratory, Universidade Feevale, Rua Rubem Berta, 200, Novo Hamburgo, RS, CEP, 93525-080, Brazil. Hauptthemen laut MEDLINE: Carbamazepine, Epilepsy, Feasibility Studies, Medication Adherence. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
Background
Fingerprint drug concentrations can be used as a noninvasive and convenient alternative to evaluate adherence to pharmacotherapy.
Methods
Fingerprints were applied over glass slides, extracted and analyzed by ultra-high performance LC-MS/MS. The assay and drug adherence questionnaires were applied to 30 epilepsy patients.
Results
The assay had linearity in the range 0.05-10 ng fingerprint-1, with precision of 2.16-7.9% and accuracy of 95.0-102.8%. Carbamazepine (CBZ) levels in fingerprints were stable at 45°C for 15 days. Concentrations in patient samples were 0.06-9.28 ng fingerprint-1. A significant difference (p = 0.003) was found between CBZ concentrations in fingerprints between patient groups divided as low and medium/high adherence.
Conclusion
This method can potentially be applied to the identification of epilepsy patients with low adherence to CBZ pharmacotherapy. [Box: see text].
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Analytical Toxicology Laboratory, Universidade Feevale, Rua Rubem Berta, 200, Novo Hamburgo, RS, CEP, 93525-080, Brazil.
- Graduate Program on Toxicology and Analytical Toxicology, Universidade Feevale, Rua Rubem Berta, 200, Novo Hamburgo, RS, CEP, 93525-080, Brazil.
- College of Medicine, Universidade de Passo Fundo, Rua Teixeira Soares, 817, Passo Fundo, RS, CEP, 99010-080, Brazil.
- College of Pharmacy, Universidade de Passo Fundo, Rodovia BR 285, Km 293, Passo Fundo, RS, CEP, 99052-900, Brazil.
- Hospital São Vicente de Paulo, Rua Uruguai, 2050, Passo Fundo-RS, CEP, 99010-111, Brazil.
ORCID-Profile: Isadora Ritter Müller, Cassiano Matheus Forcelini, Siomara Regina Hahn, Marina Venzon Antunes, Rafael Linden
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Müller, I. R., Grandi, V. T., Santos Paulino, S. G., Villa, B., Zembruski, B. M., Forcelini, C. M., Hahn, S. R., Antunes, M. V., & Linden, R. (2024). Determination of carbamazepine in fingerprints: a feasibility study to evaluate adherence in epilepsy patients. Bioanalysis, 16(9), 415-427. https://doi.org/10.4155/bio-2023-0265
Vancouver
Müller IR, Grandi VT, Santos Paulino SG, Villa B, Zembruski BM, Forcelini CM, et al. Determination of carbamazepine in fingerprints: a feasibility study to evaluate adherence in epilepsy patients. Bioanalysis. 2024;16(9):415-427. doi:10.4155/bio-2023-0265
BibTeX
@article{Mller2024,
author = {Müller, Isadora Ritter and Grandi, Valéria Tessaro and Santos Paulino, Sarah Gondim and Villa, Bárbara De and Zembruski, Bianca Modena and Forcelini, Cassiano Matheus and Hahn, Siomara Regina and Antunes, Marina Venzon and Linden, Rafael},
title = {Determination of carbamazepine in fingerprints: a feasibility study to evaluate adherence in epilepsy patients},
journal = {Bioanalysis},
year = {2024},
volume = {16},
number = {9},
pages = {415--427},
doi = {10.4155/bio-2023-0265}
}
EUVIMED